文献速递其他结缔组织病

原发性干燥综合征合并甲状腺疾病患者恶性肿瘤与骨质疏松风险增加:T细胞的潜在意义

Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cells.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

研究纳入2018年1月至2023年9月收治的329例原发性干燥综合征(pSS)患者,其中109例合并甲状腺疾病(TD),比较两组共病发生率与免疫表型。合并TD者恶性肿瘤(14.7% vs 6.4%,P=0.01)和骨质疏松(23.9% vs 14.1%,P=0.03)发生率显著升高,TD为独立危险因素;合并TD者外周血PD1+CD3+T细胞、Th及Tc细胞比例升高,唾液腺PD1+Th细胞比例亦升高。

要点

  • pSS合并TD患者恶性肿瘤发生率14.7% vs 无TD者6.4%(P=0.01)。
  • pSS合并TD患者骨质疏松发生率23.9% vs 无TD者14.1%(P=0.03)。
  • TD共病为恶性肿瘤(HR 4.7)与骨质疏松(HR 3.7)的独立危险因素。

核心结论

  • pSS合并TD患者恶性肿瘤与骨质疏松的发生风险显著升高,PD1+T细胞比例显著升高可能影响该过程。

研究设计与样本

  • 纳入2018年1月至2023年9月收治的329例确诊pSS患者,按有无甲状腺疾病分为两组,记录SS起病时临床数据,采用Kaplan-Meier法与Cox比例风险模型进行生存分析,并用流式细胞术与免疫荧光分析淋巴细胞亚型。

主要发现

  • 329例中109例合并TD,最常见类型为甲状腺结节(40.4%)和自身免疫性甲状腺疾病(28.4%)。
  • 合并TD者恶性肿瘤发生率14.7% vs 无TD者6.4%(P=0.01)。
  • 合并TD者骨质疏松发生率23.9% vs 无TD者14.1%(P=0.03)。
  • TD共病为恶性肿瘤的独立危险因素(HR 4.7,95%CI 1.1-19.3,P=0.03),亦为骨质疏松的独立危险因素(HR 3.7,95%CI 1.3-10.2,P=0.01)。
  • 合并TD者外周血总CD3+T细胞、Th细胞及Tc细胞中PD1+亚群比例均较高(均P=0.03),未转换记忆B细胞比例较低(P=0.01);唾液腺Th细胞PD1+亚群比例较无TD者(P=0.03)及对照组(P<0.01)显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the impact of thyroid diseases (TDs) on the comorbidities incidence and immune system of patients with primary SS (pSS). METHODS: A total of 329 patients diagnosed with pSS who were admitted between January 2018 and September 2023 were evaluated. The patients were divided into two groups: those with and without TD. Clinical data at the onset of SS were recorded. Kaplan-Meier method and Cox proportional hazards model were utilized for survival analysis. Flow cytometry and immunofluorescence measurements were used to analyse the lymphocyte subtypes. RESULTS: Of the 329 patients, 109 had TD. The most common types of TD were thyroid nodules (40.4%) and autoimmune thyroid diseases (AITDs) (28.4%). Patients with TD exhibited a significantly elevated incidence risk of malignancy (14.7% vs. 6.4%, P = 0.01) and osteoporosis (OP) (23.9% vs. 14.1%, P = 0.03). TD comorbidity was an independent risk factor of malignancy (HR 4.7, 95% CI 1.1-19.3, P = 0.03) and OP (HR 3.7, 95% CI 1.3-10.2, P = 0.01). Patients with SS and TD exhibited a higher ratio of programmed death-1 (PD1) + subsets of total CD3+ T cells, Th and Tc cells (all P = 0.03), as well as a lower ratio of unswitched memory B cells (P = 0.01) in peripheral blood. The ratio of PD1+ subsets of Th cells in salivary glands also exhibited a significantly increase in these patients compared with those without TD (P = 0.03) and the controls (P < 0.01). CONCLUSION: The incidence risk of malignancy and OP was significantly elevated in pSS patients with TD. The significant elevated proportions of PD1+ T cells may influence the occurrence of this process.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Cui X, Li J, Sang Y, et al. Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cells. Rheumatology (Oxford). 2025. PMID: 39672804. doi:10.1093/rheumatology/keae627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。